Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Tuberculin PPD for Anogenital Warts
NCT07072065Phase 2Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Apr 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
A Phase 2 trial of tuberculin purified protein derivative in anogenital warts, sponsored by Universitas Padjadjaran. Started Apr 2022; status: completed.
02
Drugs
tuberculin purified protein derivative
03
Conditions
anogenital warts
Beyond the preview
Go deeper on NCT07072065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07072065.